Personalized drug discovery for blood cancer.
This company is not in the game right now, so it has no score sheet.
Points come from real numbers anyone can check: new job posts, site traffic, software downloads and confirmed news. How scoring works
Facts from Y Combinator’s public list, last updated Nov 15. A free game. No real money. Points are a game score, not a judgment of what a company is worth.
Something wrong, or want this page gone? Fix or remove this page. Removal requests from a company's team are always honored. Founder of Notable Labs? Claim this page for a Founder-verified badge and your own pitch.
Tests blood cancer patients' own cells against many drugs with AI, to find treatments that work for each person.
Think of it as Consumer Reports for blood cancer drugs: it tests options before you commit.
Blood cancer patients often start with a standard drug that fails them, and doctors find out only after weeks or months of trial and error. Drugmakers also spend years and large sums finding new drugs that work for specific patient groups.
The company takes a small sample of a patient's cancer cells and runs them through an automated lab against a library of drugs. Machine learning software reads the results and ranks which drugs and combinations are most likely to kill those cells.
Drugmakers usually pay through partnership deals with upfront fees and milestone payments tied to drug progress, and some hospitals or clinics may pay per test.
This is a crowded field of AI drug discovery and precision cancer medicine, with many startups and large diagnostic and pharma players. Notable Labs sits at the point where lab testing on real patient cells meets drug discovery software.
Why now: Lab robotics, cheaper sequencing, and machine learning now let companies test thousands of drug combinations on small patient samples in weeks.
Written by AI from the company's public site. Not checked by the company. Something wrong? Fix it.